Cargando…
Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a difficult to treat tumor with a poor prognosis. Aspartate β-hydroxylase (ASPH) is a highly conserved enzyme overexpressed on the cell surface of both murine and human HCC cells. METHODS: We evaluated therapeutic effects of nanoparticle lambda...
Autores principales: | Iwagami, Yoshifumi, Casulli, Sarah, Nagaoka, Katsuya, Kim, Miran, Carlson, Rolf I., Ogawa, Kosuke, Lebowitz, Michael S., Fuller, Steve, Biswas, Biswajit, Stewart, Solomon, Dong, Xiaoqun, Ghanbari, Hossein, Wands, Jack R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619992/ https://www.ncbi.nlm.nih.gov/pubmed/28971150 http://dx.doi.org/10.1016/j.heliyon.2017.e00407 |
Ejemplares similares
-
Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013) -
Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
por: Biswas, Biswajit, et al.
Publicado: (2013) -
Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
por: Bai, Xuewei, et al.
Publicado: (2022) -
A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
por: Fuller, Steven, et al.
Publicado: (2014) -
Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013)